Effect of the combination of remifentanil and neuromuscular blockers in pediatric endotracheal intubation: a prospective, double-blinded, randomized clinical trial
- PMID: 40820133
- PMCID: PMC12359987
- DOI: 10.1186/s12887-025-06010-y
Effect of the combination of remifentanil and neuromuscular blockers in pediatric endotracheal intubation: a prospective, double-blinded, randomized clinical trial
Abstract
Background: Endotracheal intubation must be performed more carefully in children than in adults, as children are likely to more serious consequences due to the buck, move, and hemodynamic changes during the procedure. The aim of this study was to explore whether increasing the use of remifentanil during anesthesia induction can further improve the effectiveness and safety of tracheal intubation in children.
Design: This double-blind clinical trial included patients who underwent elective surgery under general anesthesia for intubation at Beijing Children's Hospital.
Methods: One hundred thirty-eight pediatric patients aged 1-12 years, classified as having American Society of Anesthesiologists (ASA) physical status I or II, who received general anesthetics for elective surgery were randomly divided into a remifentanil group (group R) (n = 69) and a placebo group (group C) (n = 69). In group R, 1 µg/kg remifentanil was intravenously infused after the intravenous infusion of other induction drugs. In group C, the same volume of normal saline was injected intravenously. The primary outcome measure was successful intubation at the first attempt with no adverse events.
Results: In total, 129 patients (64 in the group R and 65 in the group C) were enrolled. The incidence of first-attempt successful tracheal intubation with no adverse events was greater in group R (87.5%, n = 56) than in group C (60.0%, n = 39) (OR, 4.7; 95% CI = 1.9-11.4; p < 0.001).
Conclusions: Compared with the use of cisatracurium alone, the combination of low-dose remifentanil with cisatracurium was associated with a higher rate of successful first-attempt intubation without adverse events.
Trial registration: Chinese Clinical Trial Registry. Retrospectively registered. Identifier: ChiCTR2400089691. Date: 13/9/2024.
Keywords: Intubation-related adverse events; Pediatric; Remifentanil.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This clinical trial was approved by the Ethics Committee of Beijing Children’s Hospital, Capital Medical University (approval number: [2024]-Y-048-D, date of approval: 15/3/2024) and registered in the Chinese Clinical Trial Registry (registration number: ChiCTR2400089691; date of registration: 13/9/2024). All methods were performed in accordance with the Declaration of Helsinki. All the legal guardians of the children enrolled in the study signed informed consent forms before their child were enrolled in the study. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
Figures
Similar articles
-
Remifentanil for tracheal intubation without neuromuscular blocking drugs in adult patients: a systematic review and meta-analysis.Anaesthesia. 2024 Jul;79(7):759-769. doi: 10.1111/anae.16255. Epub 2024 Feb 25. Anaesthesia. 2024. PMID: 38403817
-
Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.Cochrane Database Syst Rev. 2017 May 17;5(5):CD009237. doi: 10.1002/14651858.CD009237.pub2. Cochrane Database Syst Rev. 2017. PMID: 28513831 Free PMC article.
-
Efficacy and safety of remimazolam combined with remifentanil for sedation during awake fiberoptic intubation: a randomized controlled trial.Ann Med. 2025 Dec;57(1):2527951. doi: 10.1080/07853890.2025.2527951. Epub 2025 Jul 3. Ann Med. 2025. PMID: 40605581 Free PMC article. Clinical Trial.
-
Comparison of Hemodynamic Status with Three Different Doses of Lidocaine as an Adjunct to Propofol-Remifentanil During Endotracheal Intubation in Elderly Female Patients: A Prospective Randomized Study.Drug Des Devel Ther. 2025 Jul 29;19:6461-6468. doi: 10.2147/DDDT.S534226. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 40756264 Free PMC article. Clinical Trial.
-
Supraglottic airway devices versus tracheal intubation for airway management during general anaesthesia in obese patients.Cochrane Database Syst Rev. 2013 Sep 9;2013(9):CD010105. doi: 10.1002/14651858.CD010105.pub2. Cochrane Database Syst Rev. 2013. PMID: 24014230 Free PMC article.
References
-
- Morray JP, Geiduschek JM, Caplan RA, et al. A comparison of pediatric and adult anesthesia closed malpractice claims. Anesthesiology. 1993;78:461–7. - PubMed
-
- Tamire T, Garbessa B, Gebeyehu G, et al. Tracheal intubation-related adverse events in pediatrics anesthesia in Ethiopia. Paediatr Anaesth. 2021;31:515–21. - PubMed
-
- Short CE, Bufalari A. Propofol anesthesia. Vet Clin North Am Small Anim Pract. 1999;29:747–78. - PubMed
-
- Sepulveda PO, Mora X. Reevaluation of the time course of the effect of propofol described with the Schnider pharmacokinetic model. Rev Esp Anestesiol Reanim. 2012;59:542–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources